Human immunodeficiency virus‐associated psoriasis and psoriatic arthritis treated with infliximab

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Dermatology

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.0007-0963.2004.05885.xPMID 15099388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infliximab in the treatment of an HIV positive patient with Reiter's syndrome.

  2003cited by this paper
• The effectiveness of tumor necrosis factor alpha antibody (infliximab) in treating recalcitrant psoriasis: a report of 2 cases.

  2002cited by this paper
• Binding and functional comparisons of two types of tumor necrosis factor antagonists.

  2002cited by this paper
• Cytokine gene polymorphisms in psoriasis

  2001cited by this paper
• TUMOUR NECROSIS FACTOR AS A THERAPEUTIC TARGET IN RHEUMATOID ARTHRITIS AND OTHER CHRONIC INFLAMMATORY DISEASES: THE CLINICAL EXPERIENCE WITH INFLIXIMAB (REMICADE™)

  2001cited by this paper
• Treatment of psoriatic arthritis with antitumour necrosis factor‐α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

  2001cited by this paper
• Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis.

  2000cited by this paper
• HIV-Associated Psoriasis

  2000cited by this paper
• Cytokine expression patterns distinguish HIV associated skin diseases

  2000cited by this paper
• Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.

  2000cited by this paper
• [HIV-associated psoriasis. Clinical and histological observations in 36 patients].

  1998cited by this paper
• Patterns of cytokine production in psoriatic synovium.

  1998cited by this paper
• HIV-assoziierte Psoriasis Klinische und histologische Beobachtungen an 36 Patienten

  1998cited by this paper
• Elevated tumour necrosis factor‐alpha (TNF‐α) biological activity in psoriatic skin lesions

  1994cited by this paper

• HIV - Inflammatory Dermatoses.

  2023cites this paper
• TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors

  2022cites this paper
• Infliximab, Golimumab, and Certolizumab Pegol

  2020cites this paper
• Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

  2020cites this paper
• HIV‐associated psoriasis: Epidemiology, pathogenesis, and management

  2019influential citation
• [Psoriasis and HIV infection, what do French dermatologists do?]

  2019cites this paper
• Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study

  2018cites this paper
• Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections.

  2018cites this paper
• New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management

  2018cites this paper
• A Review of Biologics and Other Treatment Modalities in HIV-Associated Psoriasis

  2018influential citation
• The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

  2018cites this paper
• Chapter 113 – Rheumatic Manifestations of Human Immunodeficiency Virus Infection

  2017cites this paper
• The effect of Helicobacter pylori eradication on psoriasis course

  2017cites this paper
• Détection et impact d’une séropositivité VIH chez les patients atteints de psoriasis. Une enquête de pratiques

  2017cites this paper
• Other Psoriasiform Dermatoses in HIV Infection

  2017cites this paper
• Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS.

  2016cites this paper
• HIV/AIDS and rheumatoid arthritis.

  2015cites this paper
• Safety issues and concerns of new immunomodulators in rheumatology

  2015cites this paper
• Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues

  2015cites this paper
• Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection

  2015cites this paper
• HIV / AIDS and rheumatoid arthritis F

  2015influential citation
• Infliximab and Golimumab

  2014cites this paper
• Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient.

  2014cites this paper
• Treatment of Refractory Psoriasis with Ustekinumab in an HIV-Positive Patient: A Case Presentation and Review of the Biologic Literature

  2014cites this paper
• 113 – Rheumatic Manifestations of Human Immunodeficiency Virus Infection

  2013cites this paper
• Succès d’une thérapie ciblée par agents anti-TNFα dans l’arthrite associée au virus de l’immunodéficience humaine. Étude de trois cas en Arabie Saoudite

  2013cites this paper
• The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.

  2013cites this paper
• Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.

  2013cites this paper
• Human immunodeficiency virus (HIV) infection and rheumatoid arthritis

  2013cites this paper
• Tratamiento de la psoriasis con fármacos anti-TNF-α en pacientes con infección por el virus de la inmunodeficiencia humana

  2012cites this paper
• [Treatment of psoriasis with anti-TNF drugs in human immunodeficiency virus-infected patients].

  2012cites this paper
• Biologic Therapy in Inflammatory Bowel Disease—A Gastrointestinal Perspective

  2012cites this paper
• Complete Resolution of Erythrodermic Psoriasis in an HIV and HCV Patient Unresponsive to Antipsoriatic Treatments after Highly Active Antiretroviral Therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir)

  2012cites this paper
• Sexually transmitted infections and sexually transmitted diseases

  2011influential citation
• Clinical Manifestations of HIV Infections

  2011cites this paper
• New insights into HIV-1-primary skin disorders

  2011cites this paper
• Treatment of Psoriasis in HIV-Infected Persons

  2011cites this paper
• The Complex Management of Viral-Related Autoimmune Diseases

  2011cites this paper
• Psoriasis: highlights on pathogenesis, adjuvant therapy, and treatment of resistant and problematic cases (II)

  2011cites this paper
• 4 – The psoriasiform reaction pattern

  2010cites this paper
• The risk of infections with biologic therapies for rheumatoid arthritis.

  2010cites this paper
• Tumor necrosis factor blockade and the risk of viral infection

  2010cites this paper
• Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.

  2010cites this paper
• Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.

  2010cites this paper
• HIV-associated psoriasis: pathogenesis, clinical features, and management.

  2010cites this paper
• Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease

  2010cites this paper
• Tratamiento de la psoriasis moderada-grave con etanercept en pacientes con infección crónica por el virus de la inmunodeficiencia humana

  2010cites this paper
• Chapitre 58 – Biothérapies et anticorps monoclonaux

  2010cites this paper
• Tratamiento con antifactor de necrosis tumoral en pacientes con artritis psoriásica e infección por el virus de la inmunodeficiencia humana

  2009cites this paper
• Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

  2009cites this paper
• Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab.

  2009cites this paper
• [Anti-tumour necrosis factor treatment in HIV-positive patients with psoriatic arthritis].

  2009cites this paper
• TNFalpha blockade in human diseases: an overview of efficacy and safety.

  2008cites this paper
• Psoriasis e infección por el virus de la inmunodeficiencia humana

  2008cites this paper
• TNFα blockade in human diseases : An overview of efficacy and safety

  2008cites this paper
• Therapy Insight: the changing spectrum of rheumatic disease in HIV infection

  2008cites this paper
• [Psoriasis and HIV infection].

  2008cites this paper
• The impact of treatment with tumour necrosis factor‐α antagonists on the course of chronic viral infections: a review of the literature

  2008cites this paper
• Treatment of rheumatic diseases in patients with HCV and HIV infection.

  2008cites this paper
• Seguridad de adalimumab

  2008cites this paper
• Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.

  2008cites this paper
• Psoriasis in the patient with human immunodeficiency virus, Part 2: Review of treatment.

  2008cites this paper
• To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.

  2008cites this paper
• Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.

  2007cites this paper
• Thérapeutiques anti-TNF-α des rhumatismes inflammatoires et infection virale prévalente

  2007cites this paper
• Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.

  2007cites this paper
• Use of infliximab to treat psoriatic arthritis in HIV-positive patients.

  2007cites this paper
• Utilisation de l'infliximab dans le traitement du rhumatisme psoriasique au cours de l'infection par le virus de l'immunodéficience humaine (VIH)

  2007cites this paper
• The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease

  2007cites this paper
• TNFalpha antagonist therapy in patients with joint disease and chronic viral infection.

  2007cites this paper
• Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients

  2006cites this paper
• Clinical applications of the polymerase chain reaction: an update.

  2006cites this paper
• Impact of biologic agents on infectious diseases.

  2006cites this paper
• Problems encountered during anti-tumour necrosis factor therapy.

  2006cites this paper
• Psoriasis and Co-Morbidities: Approach to Treatment with Biologics

  2006cites this paper
• A review of the treatment of psoriasis with infliximab.

  2006cites this paper
• [GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease].

  2005cites this paper
• Treatment advances in psoriatic arthritis

  2005cites this paper
• Recomendaciones GETECCU-2005 para el uso de infliximab (Remicade®) en la enfermedad inflamatoria intestinal

  2005cites this paper
• Corrigenda

  2004cites this paper
• Guidelines for the Treatment of Psoriatic Arthritis with Biologics the British Society for Rheumatology 2012 Guidelines for the Treatment of Psoriatic Arthritis with Biologics

  year unknowncites this paper
• Open Access Rheumatology: Research and Reviews Dovepress Rheumatoid Arthritis in Patients with Hiv: Management Challenges

  year unknowncites this paper